Results 41 to 50 of about 1,188 (177)

Genetic polymorphism in matrix metalloproteinase-9 and transforming growth factor-β1 and susceptibility to combined pulmonary fibrosis and emphysema in a Chinese population

Kaohsiung Journal of Medical Sciences, 2017
In this study, we aimed to explore the association of genetic polymorphism in matrix metalloproteinase-9 (MMP-9) and transforming growth factor-β1 (TGF-β1) and the susceptibility to combined pulmonary fibrosis and emphysema (CPFE).
Ling Xu, Wei Bian, Xiao-Hua Gu, Ce Shen
doaj   +1 more source

Phenotypic Analysis of Pulmonary Hypertension Associated With Low Diffusion Capacity and Preserved Lung Function. [PDF]

Pulm Circ
ABSTRACT Severe diffusion impairment in pulmonary arterial hypertension (PAH), particularly in idiopathic PAH (IPAH), has garnered considerable attention. However, comprehensive data on low diffusion capacity of the lungs for carbon monoxide (DLCO) with preserved lung function remain limited in broader pulmonary hypertension (PH) cohorts.
Zhao QH, Zhang R, Liu SF, Luo CJ, Qiu HL, Wu WH, Li HT, He J, Yuan P, Xu J, Liu JM, Gong SG, Wang L.   +12 more
europepmc   +2 more sources

Combined Pulmonary Fibrosis and Emphysema Syndrome Complicated by Lung Cancer

Southern Clinics of Istanbul Eurasia, 2018
Combined pulmonary fibrosis and emphysema syndrome (CPFE) is a rare disease characterized by emphysema in the upper lobes of the lung and fibrosis in the lower lobes. CPFE is an important risk factor for lung cancer (LC). Although CPFE might increase the
Nesrin Kıral Gürbüz, Saadet Akkuş, Banu Salepçi, Sevda Şener Cömert, Elif Torun Parmaksız, Coşkun Doğan   +5 more
doaj   +1 more source

Pirfenidone combined with N-acetylcysteine in treatment of pulmonary fibrosis: a case report and literature review [PDF]

Xin yixue, 2022
Objective To evaluate the efficacy and safety of pirfenidone combined with N-acetylcysteine （NAC） in the treatment of pulmonary fibrosis, aiming to provide basis for clinical medication. Methods Clinical data of 1 patient with combined pulmonary fibrosis
Li Wenjuan, Zhang Liyi, Zhou Yuqi
doaj   +1 more source

Combined pulmonary fibrosis with emphysema in nonsmokers needs connective tissue disease workup: A case report

The Journal of Association of Chest Physicians, 2023
Combined pulmonary fibrosis and emphysema (CPFE) is a heterogenous lung disease documented in smokers, which includes emphysema in upper lobes and pulmonary fibrosis in lower lobes. CPFE in nonsmokers is rare, and very few literatures are available.
Shital Patil, Sham Toshniwal
doaj   +1 more source

Pulmonary Artery Aneurysm Thrombosis with Combined Pulmonary Fibrosis and Emphysema: A Case Report [PDF]

Journal of Clinical and Diagnostic Research, 2016
We report a rare case of Pulmonary Artery Aneurysm (PAA) thrombosis with Combined Pulmonary Fibrosis and Emphysema (CPFE) with pulmonary hypertension. A 75-year-old male presented with haemoptysis, dyspnoea, clubbing and bilateral fine end inspiratory ...
Mitali Bharat Agrawal, Nilkant Tukaram Awad   +1 more
doaj   +1 more source

Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE) - Table 2

, 2016
Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE) - Table
Matthias Griese (46185), Andriana I. Papaioannou (361264), Georgia Papadaki (2851979), Aris Spathis (298607), Argyro Mazioti (2851997), Konstantinos Kostikas (361271), Ilias Papanikolaou (2851985), Stelios Loukides (2851982), Ioannis Tomos (2851988), Petros Karakitsos (298619), Effrosyni D. Manali (2851991), Aneza Roussou (2851976), Spyros Papiris (999), Kyriakos Chainis (2851994)   +13 more
core   +1 more source

Differentiating combined pulmonary fibrosis and emphysema from pure emphysema: utility of late gadolinium-enhanced MRI

European Radiology Experimental, 2020
Background Differentiating combined pulmonary fibrosis with emphysema (CPFE) from pure emphysema can be challenging on high-resolution computed tomography (HRCT). This has antifibrotic therapy implications.
Hannah Fleming, Simon M. Clifford, Aoife Haughey, Roisin MacDermott, Niall McVeigh, Gerard M. Healy, Lisa Lavelle, Suhny Abbara, David J. Murphy, Aurelie Fabre, Edward McKone, Cormac McCarthy, Marcus Butler, Peter Doran, David A. Lynch, Michael P. Keane, Jonathan D. Dodd   +16 more
doaj   +1 more source

Clinical characteristics of combined pulmonary fibrosis and emphysema [PDF]

, 2010
The definitive version is available at www.blackwell-synergy.comBackground and objective: Patients with combined pulmonary fibrosis and emphysema (CPFE) are sometimes seen, and we speculate that these patients have some different clinical characteristics
Masayuki HANAOKA, Takayuki HONDA, Yoshiaki KITAGUCHI, Keisaku FUJIMOTO, Satoshi KAWAKAMI, Keishi KUBO, Kubo, Keishi, Fujimoto, Keisaku, Kitaguchi, Yoshiaki, Honda, Takayuki, Kawakami, Satoshi, Hanaoka, Masayuki   +11 more
core   +1 more source

Xenon-Enhanced Dual-Energy CT Imaging in Combined Pulmonary Fibrosis and Emphysema. [PDF]

PLoS ONE, 2017
Little has been reported on the feasibility of xenon-enhanced dual-energy computed tomography (Xe-DECT) in the visual and quantitative analysis of combined pulmonary fibrosis and emphysema (CPFE).We compared CPFE with idiopathic pulmonary fibrosis (IPF ...
Keishi Sugino, Masahiro Kobayashi, Yasuhiko Nakamura, Kyoko Gocho, Fumiaki Ishida, Kazutoshi Isobe, Nobuyuki Shiraga, Sakae Homma   +7 more
doaj   +1 more source